Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma

This study has suspended participant recruitment.

(Temporarily suspended to new patient registration)

Sponsor:

Information provided by (Responsible Party):

National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:

NCT01604772

First received: May 22, 2012

Last updated: March 18, 2013

Last verified: March 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has suspended participant recruitment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	July 2013 (Final data collection date for primary outcome measure)